MEDMIRA INC (MIR.CA) Stock News

TSX-V:MIR - TSX Venture Exchange - CA58501R1029 - Common Stock - Currency: CAD

0.07 0 (-6.67%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MIR.CA Latest News, Press Relases and Analysis

All

Press Releases

17 days ago - By: ACCESS Newswire

MedMira Announces Launch of Clinical Trial for Its Multiplo(R) TP/HIV Self-Test in Canada

24 days ago - By: ACCESS Newswire

MedMira Reports Second Quarter Results FY2025

3 months ago - By: ACCESS Newswire

MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal(R) G4 HIV-1/2 rapid test for VA, Department of Defense

4 months ago - By: ACCESS Newswire

MedMira Reports Second Quarter Results FY2025

5 months ago - By: ACCESS Newswire

MedMira Announces Partnership with MediGroup Physician Services in the United States

5 months ago - By: ACCESS Newswire

MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada

6 months ago - By: ACCESS Newswire

MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications

2 years ago - By: Maternova, Inc. - Mentions: TSX

Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis

3 years ago - By: MedMira Inc.

MedMira Strengthens and Expands Board

3 years ago - By: MedMira Inc.

MedMira Reports Third Quarter Results FY2022

3 years ago - By: MedMira Inc.

MedMira Receives Patent for its Unique Quantitative Diagnostic System

3 years ago - By: MedMira Inc.

MedMira provides an update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market